Clinical Trial Update: Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intranasal ketamine with repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Intranasal ketamine (ketamine)
• RTMS (Repetitive transcranial magnetic stimulation)

Snippet

Sponsor: University of Cincinnati | Conditions: Major Depressive Disorder | Phase 4 | Status: UNKNOWN